{"id":"https://openalex.org/W2397847142","doi":null,"title":"Influence of NG-nitro-L-arginine on the anticonvulsant and acute adverse effects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice.","display_name":"Influence of NG-nitro-L-arginine on the anticonvulsant and acute adverse effects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice.","publication_year":2006,"publication_date":"2006-11-01","ids":{"openalex":"https://openalex.org/W2397847142","mag":"2397847142","pmid":"https://pubmed.ncbi.nlm.nih.gov/17220555"},"language":"en","primary_location":{"id":"pmid:17220555","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17220555","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009737999","display_name":"Jarogniew Jacek \u0141uszczki","orcid":"https://orcid.org/0000-0002-3059-0393","observed_orcids":["https://orcid.org/0000-0002-3059-0393"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Jarogniew J Luszczki","raw_affiliation_strings":["Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, PL 20-090 Lublin, Poland. jarogniew.luszczki@am.lublin.pl","Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, PL-20-090 Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, PL 20-090 Lublin, Poland. jarogniew.luszczki@am.lublin.pl","institution_ids":["https://openalex.org/I121032520"]},{"raw_affiliation_string":"Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, PL-20-090 Lublin, Poland","institution_ids":["https://openalex.org/I121032520"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022451015","display_name":"Miros\u0142aw Czuczwar","orcid":"https://orcid.org/0000-0002-9025-6717","observed_orcids":["https://orcid.org/0000-0002-9025-6717"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miros\u0142aw Czuczwar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088424602","display_name":"Piotr J. Gawlik","orcid":"https://orcid.org/0000-0002-9522-9806","observed_orcids":["https://orcid.org/0000-0002-9522-9806"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piotr Gawlik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044755956","display_name":"Grazyna Sawiniec-P\u00f3\u017aniak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grazyna Sawiniec-P\u00f3\u017aniak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039552724","display_name":"Katarzyna Czuczwar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katarzyna Czuczwar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072488610","display_name":"Katarzyna Sawicka","orcid":"https://orcid.org/0000-0002-3915-1899","observed_orcids":["https://orcid.org/0000-0002-3915-1899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katarzyna M Sawicka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000786735","display_name":"Monika Dudra-Jastrz\u0119bska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monika Dudra-Jastrzebska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078348855","display_name":"Stanis\u0142aw Jerzy Czuczwar","orcid":"https://orcid.org/0000-0003-2879-9945","observed_orcids":["https://orcid.org/0000-0003-2879-9945"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stanis\u0142aw J Czuczwar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9909,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.84703127,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"58","issue":"6","first_page":"955","last_page":"60"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ng-nitro-l-arginine","display_name":"L-NNA","score":0.9110000133514404},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.8360000252723694},{"id":"https://openalex.org/keywords/nitric-oxide-synthase-inhibition","display_name":"nitric oxide synthase inhibition","score":0.9610000252723694},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9369999766349792},{"id":"https://openalex.org/keywords/felbamate","display_name":"felbamate","score":0.8379999995231628},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":1.0},{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":1.0},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":1.0},{"id":"https://openalex.org/keywords/maximal-electroshock-seizures","display_name":"maximal electroshock seizures","score":0.8389999866485596},{"id":"https://openalex.org/keywords/anticonvulsant-activity","display_name":"anticonvulsant activity","score":0.7889999747276306},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6790000200271606},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.8242078423500061},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.768456220626831},{"id":"https://openalex.org/C2781011581","wikidata":"https://www.wikidata.org/wiki/Q421301","display_name":"Felbamate","level":4,"score":0.6691758632659912},{"id":"https://openalex.org/C2781176495","wikidata":"https://www.wikidata.org/wiki/Q176301","display_name":"Oxcarbazepine","level":4,"score":0.6459137797355652},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.5735657215118408},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.5543182492256165},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5387974381446838},{"id":"https://openalex.org/C2776749334","wikidata":"https://www.wikidata.org/wiki/Q907219","display_name":"Tiagabine","level":4,"score":0.4997522830963135},{"id":"https://openalex.org/C2776819090","wikidata":"https://www.wikidata.org/wiki/Q412391","display_name":"Pentylenetetrazol","level":4,"score":0.470990389585495},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46825820207595825},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41591233015060425},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37674540281295776},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.18735763430595398},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078328","descriptor_name":"Felbamate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078330","descriptor_name":"Oxcarbazepine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004597","descriptor_name":"Electroshock","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009569","descriptor_name":"Nitric Oxide","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D011409","descriptor_name":"Propylene Glycols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019335","descriptor_name":"Nitroarginine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17220555","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17220555","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},{"id":"mag:2397847142","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17220555","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W214908574","https://openalex.org/W1883906051","https://openalex.org/W1963511216","https://openalex.org/W1968228025","https://openalex.org/W1971680727","https://openalex.org/W1979994394","https://openalex.org/W1987460794","https://openalex.org/W1987721729","https://openalex.org/W2007578082","https://openalex.org/W2016230171","https://openalex.org/W2025652380","https://openalex.org/W2031833127","https://openalex.org/W2033389202","https://openalex.org/W2057479349","https://openalex.org/W2059640915","https://openalex.org/W2062982587","https://openalex.org/W2070663619","https://openalex.org/W2085429609","https://openalex.org/W2100043761","https://openalex.org/W2111514777","https://openalex.org/W2162500611","https://openalex.org/W2401188729","https://openalex.org/W2412638650","https://openalex.org/W2418189182","https://openalex.org/W4406065882"],"related_works":["https://openalex.org/W2413107201","https://openalex.org/W2127666007","https://openalex.org/W2045883720","https://openalex.org/W1971680727","https://openalex.org/W1965780422","https://openalex.org/W2418189182","https://openalex.org/W2106457141","https://openalex.org/W2151160854","https://openalex.org/W2100043761","https://openalex.org/W2031833127"],"abstract_inverted_index":{"Overwhelming":[0],"evidence":[1],"indicates":[2],"that":[3,31,95],"nitric":[4],"oxide":[5],"(NO)":[6],"plays":[7],"an":[8],"important":[9],"role":[10],"in":[11,16,39,80,91,164,205,209],"epileptogenesis":[12],"and":[13,36,62,77,87,117,127,136,179,192,203],"seizure":[14,85],"activity":[15,106,189],"the":[17,40,50,60,81,88,104,112,131,145,155,160,165,170,174,193,198,206],"brain.":[18,41],"The":[19,42],"results":[20],"of":[21,44,52,66,107,115,121,134,159,173,177,183,190,195,201],"experimental":[22],"studies":[23],"on":[24,59],"animals":[25],"provide,":[26],"however,":[27],"discrepant":[28],"information":[29],"reporting":[30],"NO":[32,56,146,196],"has":[33],"both":[34],"anti-":[35],"pro-convulsant":[37,188],"action":[38,114],"objective":[43],"this":[45],"study":[46],"was":[47,123],"to":[48],"determine":[49],"effect":[51],"N(G)-nitro-L-arginine":[53],"(L-NA--a":[54],"non-specific":[55],"synthase":[57,147],"inhibitor)":[58],"anticonvulsant":[61,132,175],"acute":[63,156],"adverse-effect":[64,157],"profiles":[65,158],"four":[67],"second-generation":[68],"antiepileptic":[69,162],"drugs":[70,163],"(felbamate":[71],"[FBM],":[72],"lamotrigine":[73],"[LTG],":[74],"oxcarbazepine":[75],"[OXC]":[76],"topiramate":[78],"[TPM])":[79],"maximal":[82],"electroshock":[83],"(MES)-induced":[84],"model":[86],"chimney":[89,166],"test":[90,208],"mice.":[92,210],"Results":[93],"indicated":[94],"L-NA(at":[96],"40":[97],"mg/kg,":[98,150],"ip)":[99,151],"did":[100,152],"not":[101,153],"affect":[102],"significantly":[103],"antiseizure":[105,199],"all":[108],"examined":[109],"drugs.":[110],"However,":[111],"antielectroshock":[113],"FBM":[116,178,202],"LTG":[118,180,204],"after":[119,141,181],"co-administration":[120,182],"L-NA":[122,142,184,191],"attenuated":[124],"by":[125],"36%":[126],"28%.":[128],"In":[129,168],"contrast,":[130],"effects":[133,176],"TPM":[135],"OXC":[137],"were":[138],"almost":[139],"unchanged":[140],"administration.":[143],"Moreover,":[144],"inhibitor":[148],"(40":[149],"enhance":[154],"studied":[161],"test.":[167],"conclusion,":[169],"observed":[171],"reduction":[172],"may":[185],"suggest":[186],"a":[187],"cooperation":[194],"with":[197],"properties":[200],"MES":[207]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}